Carlos Rodríguez‐Antolín
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
-
- Epigenetics and DNA Methylation 8
- RNA modifications and cancer 5
- Extracellular vesicles in disease 2
-
- CAR-T cell therapy research 2
-
- Lung Cancer Treatments and Mutations 5
-
- Genomics and Rare Diseases 2
- Co-authors
- Inmaculada Ibañez de CáceresJavier de CastroOlga PerníaJavier SotoRosario PeronaOlga VeraCristóbal Belda-IniestaElena Vallespín
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Carlos Rodríguez‐Antolín
29 papers receiving 404 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 148
- Molecular Biology 276
- Oncology 75
- Pulmonary and Respiratory Medicine 64
- Immunology 34
Countries citing papers authored by Carlos Rodríguez‐Antolín
This map shows the geographic impact of Carlos Rodríguez‐Antolín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Rodríguez‐Antolín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Rodríguez‐Antolín more than expected).
Fields of papers citing papers by Carlos Rodríguez‐Antolín
This network shows the impact of papers produced by Carlos Rodríguez‐Antolín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Rodríguez‐Antolín. The network helps show where Carlos Rodríguez‐Antolín may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carlos Rodríguez‐Antolín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 12 | |
| 12 | 2019 | 9 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 25 | |
| 16 | 2017 | 6 | |
| 17 | 2017 | 50 | |
| 18 | 2015 | 46 | |
| 19 | 2014 | 11 | |
| 20 | 2012 | 61 |
About Carlos Rodríguez‐Antolín
Carlos Rodríguez‐Antolín is a scholar working on Cancer Research, Molecular Biology and Pharmacology, having authored 29 papers that have together received 410 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Lung Cancer Treatments and Mutations (5 papers), Genomics and Rare Diseases (2 papers), Extracellular vesicles in disease (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (148 citations), Molecular Biology (276 citations) and Oncology (75 citations). Carlos Rodríguez‐Antolín has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Inmaculada Ibañez de Cáceres, Javier de Castro, Olga Pernía, Javier Soto, Rosario Perona, Olga Vera, Cristóbal Belda-Iniesta, Elena Vallespín, María Cortés-Sempere and Manuel Nistal. Their work appears in journals such as PLoS ONE, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.